Latest Product News
Macrogen Europe Expands Sequencing Capacity
Genomic sequencing service provider Macrogen Europe has achieved a significant upgrade to its next-generation sequencing capacity.
Sphere Fluidics Announces Enhanced Cyto-Mine Capability and Performance
Sphere Fluidics has announced it has enhanced the capability and performance of its Cyto-Mine® System. The simplified design offers improved functionality to help streamline workflows, reduce costs, increase throughput, and enable high-value clones to be captured in a single run.
Bio-Rad Launches the SEQuoia RiboDepletion Kit for Next-Generation Sequencing
Bio-Rad Laboratories, Inc. has announced the launch of the SEQuoia RiboDepletion Kit, which improves assay efficiency by eliminating irrelevant ribosomal RNA (rRNA) fragments from an RNA-Seq library.
ERS Genomics and GenScript Biotech Corporation Sign CRISPR/Cas9 License Agreement
ERS Genomics Limited and GenScript Biotech Corporation have announced a non-exclusive license agreement granting GenScript access to ERS Genomics’ CRISPR/Cas9 patent portfolio.
Isohelix and AutoGen Announce Supply Agreement To Integrate DNA Extraction Workflows
Isohelix and AutoGen, Inc. have signed a far-reaching supply agreement. This follows the successful validation of the Isohelix GeneFix™ range of saliva collection products on the AutoGen FlexSTAR and FlexSTAR+ DNA extraction workflows.
Bio-Rad Launches SARS-CoV-2 Variant RT-PCR Assays
Bio-Rad Laboratories has announced the launch of the SARS-CoV-2 Variant RT-PCR Assays for research use only. The assays can detect SARS-CoV-2 variants of concern.
Fusion Antibodies Proud To Support ‘State of the Art’ Project
Northern Ireland Science Festival, in conjunction with Linen Biennale and funded by Northern Ireland Arts and Business, recently rolled out the virtual red carpet to premier Fusion Antibodies Head of Scientific Affairs, Dr Anthony O’Kane’s ‘Translating Linen.’
ERS Genomics and NUVISAN ICB Sign CRISPR/Cas9 License Agreement
ERS Genomics Limited and NUVISAN Innovation Campus Berlin (ICB) GmbH have announced a non-exclusive license agreement granting NUVISAN ICB access to ERS Genomics’ CRISPR/Cas9 patent portfolio.
Eppendorf Introduces Multipurpose Centrifuge 5910 Ri To Accelerate Results
Eppendorf has introduced a new centrifuge designed to increase efficiency in the laboratory, Centrifuge 5910 Ri.
Lonza Celebrates 20th Anniversary of Nucleofector Cell Transfection Platform
2021 marks the 20th anniversary of Lonza’s Nucleofector™ Technology, the industry’s leading non-viral cell transfection method, which has been cited more than 10,000 times, including in research by two Nobel Laureates.